Sort
261,768 grants matching “gene therapy”
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
$2,023,721Charles David Allis · Rockefeller University · P01 · FY2015 · CA
Alzheimer's DIsease Research Center
$2,023,516Steven T Dekosky · University Of Pittsburgh At Pittsburgh · P50 · FY2007 · AG
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$2,023,207Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2014 · GM
Pancreatic Cancer Development: Genetic and Immune Regulation
$2,023,000Seung K Kim · Stanford University · P01 · FY2025 · CA
Mechanisms Underlying Clearance of Persistent Infections
$2,022,862Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Pathogenesis of CNS infection and injury
$2,022,862Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
T-cell receptor gene therapy for cancer
$2,022,756Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
MAP4K3 regulation of cellular stress response pathways in health and disease
$2,022,582Albert R La Spada · University Of California-Irvine · RF1 · FY2022 · AG
GENE THERAPY FOR BRAIN TUMORS
$2,022,442Massachusetts General Hospital · P01 · FY2000 · CA
Molecular Pathways to Thynmic Lymphoma and Leukemia
$2,022,365A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Elevated mitochondrial fusion and function in Down syndrome
$2,021,900Beverly A. Rothermel · Ut Southwestern Medical Center · R01 · FY2019 · HD
Clinical Epidemiology and Pathogenesis of Asymptomatic HSV
$2,021,461Anna Wald · Fred Hutchinson Cancer Research Center · P01 · FY2012 · AI
Analysis of human autoreactive T cell receptors in vivo
$2,020,415Ronald G Gill · University Of Colorado Denver · UC4 · FY2014 · DK
SCOR in Molecular Medicine and Atherosclerosis
$2,020,076University Of California San Diego · P50 · FY2003 · HL
Human Artificial Chromosomes for Cancer Research and Functional Genomics
$2,019,980Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Sex-based Differences in Glioma
$2,019,654Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics
$2,019,222George Pappas · Schedule 1 Therapeutics, Inc. · R44 · FY2024 · DA
Hematopoietic Chimerism after Stem Cell Allografts
$2,019,079Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$2,018,756Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Defining the altered FUS-PARP-1-DNA Ligase III axis and its implications to nuclear and mitochondrial genome damage response in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
$2,018,750Muralidhar L Hegde · Methodist Hospital Research Institute · RF1 · FY2020 · NS
CELLULAR AND HUMORAL ASPECTS OF IMMUNOMODULATION
$2,018,682University Of Pennsylvania · P50 · FY2000 · HL
Role of Pluripotency Factors in Embryonic Stem Cells, Development and Disease
$2,018,502Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
SPORE IN BREAST CANCER
$2,018,501Georgetown University · P50 · FY2000 · CA
Improving the safety and efficacy of cell therapies
$2,018,471Malcolm K Brenner · Baylor College Of Medicine · U54 · FY2008 · HL
Reproductive Endocrinology And Infertility Clinical Training Program
$2,018,370James H. Segars · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD